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Ataxia and Paroxysmal Dyskinesia in Mice
Lacking Axonally Transported FGF14
et al., 1996) and FGF14 (Wang et al., 2000a; our unpub-
lished data) cannot be detected in the medium of trans-
fected cells and accumulate to high levels intracellularly,
Qing Wang,1,5 Mark E. Bardgett,2,6 Michael Wong,3
David F. Wozniak,2 Junyang Lou,1
Benjamin D. McNeil,1 Chen Chen,1 Anthony Nardi,2
David C. Reid,2 Kelvin Yamada,3 suggesting a unique mechanism of action. Multiple
splice forms of FGFs 11–14 have been identified, whichand David M. Ornitz1,4
1Department of Molecular Biology and only differ in the first exon. The alternative first exons
appear to encode dominant protein trafficking signalsPharmacology
2 Department of Psychiatry that are necessary and sufficient to target the protein
to different subcellular compartments (Munoz-Sanjuan3 Department of Neurology
Washington University School of Medicine et al., 2000; Smallwood et al., 1996; Wang et al., 2000a;
Yamamoto et al., 1998). The two forms of FGF14, FGF14-St. Louis, Missouri 63110
1a and FGF14-1b, are localized in the nucleus and cyto-
plasm of NIH3T3 cells, respectively (Wang et al., 2000a).
Fgf14 is expressed in the developing central nervousSummary
system in mice. At E12.5, Fgf14 is localized in the ventral
lining of the third and the fourth ventricles, the supraop-Fibroblast growth factor 14 (FGF14) belongs to a dis-
tic and septal areas, and spinal cord (Wang et al., 2000a).tinct subclass of FGFs that is expressed in the devel-
At this stage, Fgf14 is excluded from the neuroepithel-oping and adult CNS. We disrupted the Fgf14 gene
ium and is localized in the subventricular zone. Fgf14 isand introduced an Fgf14N--Gal allele that abolished
localized in the ventral two thirds of the developingFgf14 expression and generated a fusion protein
spinal cord, including the floor plate. Fgf14 is also(FGF14N--gal) containing the first exon of FGF14 and
expressed in several nonneuronal tissues, including-galactosidase. Fgf14-deficient mice were viable,
the thymic primordium and major arteries. In adult mice,fertile, and anatomically normal, but developed ataxia
the cytoplasmic localized form of Fgf14 (Fgf14-1b) is theand a paroxysmal hyperkinetic movement disorder.
predominant form expressed in the brain (Munoz-San-Neuropharmacological studies showed that Fgf14-
juan et al., 2000; Wang et al., 2000a; Yamamoto et al.,deficient mice have reduced responses to dopamine
1998). The expression pattern of Fgf14 suggests rolesagonists. The paroxysmal hyperkinetic movement dis-
in both neuronal development and adult brain function.order phenocopies a form of dystonia, a disease often
Importantly, Fgfs 11–14 also share overlapping but non-associated with dysfunction of the putamen. Strik-
identical expression patterns, which suggests possibleingly, the FGF14N--gal chimeric protein was effi-
functional redundancy (Smallwood et al., 1996).ciently transported into neuronal processes in the
To test the hypothesis that FGF14 participates in CNSbasal ganglia and cerebellum. Together, these studies
development or adult brain function, we disrupted theidentify a novel function for FGF14 in neuronal signal-
Fgf14 gene by replacing the second and third exonsing and implicate FGF14 in axonal trafficking and syn-
with -gal. Surprisingly, homozygous FGF14-deficientaptosomal function.
mice were viable, fertile, and anatomically normal. How-
ever, they displayed ataxia and a paroxysmal hyperki-Introduction
netic dyskinesia beginning at 3 weeks of age. These
motor abnormalities are associated with dysfunction ofFibroblast growth factor homologous factors 1–4 (FHFs
the basal ganglia system and resemble several human1–4, now termed FGFs 11–14) form a unique subfamily
dystonia syndromes.of the 22 known FGFs (Ornitz and Itoh, 2001; Smallwood
et al., 1996). They share less than 30% amino acid iden-
Resultstity with other FGFs, but retain core conserved amino
acid residues in exons 2 and 3. FGFs 11–14 share 58%–
Fgf14 Gene Targeting71% amino acid sequence identity and lack a secretory
An Fgf14 gene targeting vector (Figure 1A) was designedsignal peptide (Smallwood et al., 1996). Interactions with
to insert a -galactosidase (-gal)-Neo cassette into thethe four known FGF receptors have not been identified,
Fgf14 gene. This design placed the -gal cDNA in frameand to date, the biological function of FGFs 11–14 re-
with the first five codons of exon 2, generating a fusionmains elusive. The activity of classical FGFs is regulated
protein containing the alternatively spliced first exonsin part by cellular localization and export. In neurons,
of FGF14 fused to -gal (FGF14N--gal). This resultedexogenous FGF2 can undergo anterograde axon trans-
in deletion of exons 2 and 3, which encode the coreport in a receptor-dependent manner (Ferguson and
conserved amino acids common to all FGFs (Wang et al.,Johnson, 1991). Unlike FGFs 1 and 2, FGF12 (Smallwood
2000a). The resulting heterozygous mice (Fgf14N--Gal/
or/), generated from two independently targeted ES
4 Correspondence: dornitz@pcg.wustl.edu clones, were indistinguishable from wild-type lit-5 Current address: Department of Comparative Genomics, Phar-
termates (wt or /; Figures 1B and 1C). Homozygousmacia Incorporated, Chesterfield, Missouri 63198.
mice (Fgf14N--Gal/N--Gal or /) were viable and fertile.6 Current address: Department of Psychology, Northern Kentucky
University, Highland Heights, Kentucky 41099. FGF14 mRNA expression was assessed by RNA blot of
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Figure 1. Targeted Disruption of Fgf14 and
Growth Characteristics of Fgf14N--Gal/N--Gal
Mice
(A) Structure of the Fgf14 genomic locus (top),
targeting vector (middle), and targeted allele
(bottom). The coding exons are represented
by black boxes. The location of PolII-Neo-
loxP gene (solid bar) and -gal gene (open
bar) are indicated in the targeting vector and
mutant allele. The location of Southern blot
probes are shown. E, EcoRI; X, XbaI; B,
BamHI; Rv, EcoRV; S, SalI.
(B) Southern blot of genomic DNA from tar-
geted ES clones (lanes 1 and 2) and a wild-
type ES clone (lane 3), hybridized with 5 and
3 genomic probes.
(C) PCR genotyping of wild-type (/), het-
erozygous (/) and homozygous (/)
Fgf14N--Gal mice.
(D) RNA blot analysis of the cerebellum of
wild-type (/), heterozygous (/), and ho-
mozygous (/) mice. The left panel shows
the ethidium bromide stained gel; the posi-
tions of the 18S and 28S rRNA are indicated
by arrows. The right panel shows the autora-
diography following hybridization with a [-
32P]CTP-labeled Fgf14 cDNA probe.
(E) Representative growth curves in a pure
129/SVJ genetic background. The insert
shows the body weight comparison at age
4–5 months. Wild-type and heterozygous
mice (solid symbols and solid lines),
Fgf14N--Gal/N--Gal mice (open symbols and
dashed lines).
(F) Representative growth curve after cross-
ing five generations onto a C57B6/J genetic
background. The insert shows the body
weight comparison at age 4–5 months. *p 
0.05, **p  0.01.
total cerebellar RNA using a probe derived from exons nal sections from adult wild-type and Fgf14N--Gal/N--Gal
brains. This analysis revealed that Fgf14 transcripts2 and 3 (Figure 1D). Fgf14 mRNA was detected in wild-
were localized in hippocampal and cerebellar granuletype mice, at reduced levels in heterozygous mice, but
cells and were diffusely expressed in the cerebral cortexwas absent in Fgf14N--Gal/N--Gal mice.
and striatum (caudate-putamen, CPu) (Figures 2A–2C).During the first 2 weeks after birth, Fgf14N--Gal/N--Gal
Fgf14 transcripts were not detected in Fgf14N--Gal/N--Galpups were indistinguishable from their wild-type lit-
tissue (Figures 2D–2F), consistent with the RNA blottermates. In the third and fourth weeks, the growth of
data (Figure 1D). -gal in situ mRNA expression patternsFgf14N--Gal/N--Gal mice on a pure 129/SVJ genetic back-
in Fgf14N--Gal/N--Gal tissue (Figures 2G–2L) were essen-ground lagged behind that of wild-type littermates, but
tially the same as those of Fgf14 in wild-type tissue,thereafter maintained a parallel curve. Adult Fgf14N--Gal/
suggesting that deletion of the 3 kb intron between exonN--Gal mice remained 30% smaller than littermate con-
2 and exon 3 did not disrupt regulatory elements thattrols (n  9 per genotype, p  0.01) (Figure 1E).
control Fgf14 expression. Furthermore, RNA blot analy-Fgf14N--Gal/ mice were backcrossed five generations
sis of FGF14 regional expression in human adult brainonto the C57B6/J genetic background (G5:C57B6/J). On
(Figure 2M) showed the highest levels in the cerebellumthe G5:C57B6/J genetic background, the size of
and moderate to high levels in the hippocampus, amyg-Fgf14N--Gal/N--Gal mice was similar to that of wild-type lit-
dala, cerebral cortex, striatum, and thalamus, consistenttermates until weaning. However, adult Fgf14N--Gal/N--Gal
with in situ data on adult mouse tissue. The corpusmice failed to attain normal weight and remained 15%
callosum and substantia nigra showed no significantsmaller than their littermates (n  7 per genotype, p 
expression. These data demonstrated that the expres-0.05) (Figure 1F).
sion pattern of Fgf14 is conserved across species.
To assess the expression pattern of the FGF14N--gal
FGF14N--gal Is Expressed in the Cerebellum protein, -gal activity was localized in situ. FGF14N--gal
and Basal Ganglia and Is Efficiently was strongly expressed in the cerebellum and striatum
Trafficked into Axons and moderately expressed in the dorsal cerebral cortex,
To determine whether Fgf14N--Gal expression recapitu- hippocampus, and hypothalamus (Figures 3A–3C). Al-
lates that of Fgf14, in situ hybridization was carried out though globally consistent with the Fgf14 transcript dis-
tribution pattern determined by in situ hybridization andusing both Fgf14 and -gal cDNA probes on serial coro-
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mRNA are localized in the internal granule cell layer
(IGL), which contains the cell bodies of granule cells.
More strikingly, the corpus callosum, a region that con-
tains only a collection of fibers, was intensely stained
with X-gal (Figures 3B and 3C). In contrast, both in situ
hybridization and RNA blot showed no expression of
Fgf14 mRNA in the corpus callosum. Control transgenic
mice, which express -gal in granule cells under the
control of GABA receptor 6 subunit regulatory ele-
ments (Bahn et al., 1997; Jones et al., 1997), showed
-gal activity distributed primarily in the IGL and dif-
fusely in the ML (Figure 3F). Taken together, these data
demonstrate that the first exon of FGF14 is sufficient to
direct -gal into axons and suggest that FGF14 may
itself be trafficked into neuronal processes.
FGF14 Is Not Essential for Neuronal Development
Given that Fgf14 is widely expressed in the central ner-
vous system during embryonic development, we hy-
pothesized that loss of FGF14 may result in neuronal
malformation. However, Fgf14N--Gal/N--Gal mice are viable
and fertile and have no increased mortality over a 20
month period (Fgf14N--Gal/N--Gal, n  16; wild-type, n 
12). Examination of brain structure using three different
histological stains revealed normal organization of cell
bodies (Nissl stain; data not shown), no evidence of
demyelination (luxal fast blue; Figures 4A–4D), and no
axon degeneration (silver stain; Figures 4E–4H) in
Fgf14N--Gal/N--Gal mice at 3–4 months of age. Because
Fgf14 is expressed most strongly in the subventricular
zone of the developing CNS (Wang et al., 2000a), a region
that contains migrating neurons, we examined neuronal
migration by BrdU birth-dating (Chae et al., 1997). Preg-
nant mice were injected with BrdU at day 13 of gestation.
Coronal sections, prepared at 1 month of age from wild-
type and Fgf14N--Gal/N--Gal mice, were stained for BrdU to
identify the location of postmigratory neurons. Sections
at the level of the anterior hippocampus identified that
most BrdU-labeled neurons are localized in cortical lay-
ers IV and V in both Fgf14N--Gal/N--Gal mice (Figure 4I)
and in wild-type littermates (Figure 4J). Thus, neither
neuronal migration nor brain histology appeared to be
disrupted in mice lacking Fgf14.
Figure 2. Expression of Fgf14 and Fgf14N--Gal in the Adult Mouse
Brain and FGF14 in Human Brain
Ataxia and Paroxysmal Dyskinesia in Mice(A–L) Dark field images of in situ hybridization show the expression
Lacking Fgf14of Fgf14 (A–F) and Fgf14N--Gal (G–L) in a series of coronal sections
Initial examination of the behavior of Fgf14N--Gal/N--Galof wild-type (A–C and G–I) and Fgf14N--Gal/N--Gal (D–F and J–L) mice.
Representative sections are shown through the forebrain (A, D, G, mice revealed several neuromuscular abnormalities.
and J), midbrain (B, E, H, and K), and hindbrain (C, F, I, and L). While wild-type mice extend their hindlimbs and digits
CPu, caudate putamen; CT, cerebral cortex; DG, dentate gyrus; CB, in response to being suspended by their tail, 60% of
cerebellum.
adult Fgf14N--Gal/N--Gal mice (G5:C57B6/J background,(M) RNA blot analysis showing expression of FGF14 in different
n 10) retracted their hindfeet and clenched their digitsregions of the human brain. Band intensities were quantified by
when similarly suspended. Furthermore, Fgf14N--Gal/N--GalPhosphorImager analysis, and the data were normalized to the ex-
pression level in whole brain. mice had an ataxic gait with shuffling footprint patterns,
a widened stance, and lack of forefoot-hindfoot corre-
spondence (Figure 5A). An accelerating rotorod was
used to assess the ability of Fgf14N--Gal/N--Gal mice toRNA blot (Figure 2), X-gal staining revealed a striking
difference. Surprisingly, FGF14N--gal was efficiently coordinate movement (Figure 5B). Control mice demon-
strated an overall superior performance tolocalized in axons and was barely detectable in neuronal
cell bodies. For example, in the cerebellum (Figures 3D Fgf14N--Gal/N--Gal mice and exhibited significant improve-
ment in performance over successive trials. In contrast,and 3E), FGF14N--gal staining is most intense in the
molecular layer (ML), where the axons of granule cells the Fgf14N--Gal/N--Gal mice were able to remain on the
accelerating rod for only a few seconds, and their perfor-extend and fasciculate, while Fgf14N--Gal and Fgf14
Neuron
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Figure 3. FGF14N--gal Localization in Adult
Fgf14N--Gal/N--Gal Brain Tissue
(A) Sagittal whole mount X-gal staining of
Fgf14N--Gal/N--Gal brain from a 3-month-old
mouse. FGF14N--gal activity is seen in the
basal forebrain and cerebellum. Two yellow
arrows indicate the relative positions of the
two coronal sections shown in (B) and (C).
(B and C) X-gal staining of frozen coronal sec-
tions shows FGF14N--gal activity in the cor-
pus collosum (CC), caudate-putamen (CPu),
globus pallidus (GP), dentate gyrus (DG), and
substantia nigra pars reticulata (SNr).
(D) In situ hybridization showing Fgf14 (or
Fgf14N--Gal/N--Gal; data not shown) mRNA ex-
pression in the internal granule cell layer (IGL)
of the cerebellum.
(E) Localization of FGF14N--gal activity in
the molecular layer (ML).
(F) Localization of -gal activity in the cere-
bellum of a control mouse in which the cyto-
plasmic -gal cDNA was inserted into the GA-
BAA receptor 6 gene (Jones et al., 1997).
mance did not improve with increasing numbers of trials poor performance. The Fgf14N--Gal/N--Gal mice were also
impaired on the ledge and platform tests (Figures 5D(Figure 5B).
Because performance on the rotorod task may de- and 5E) and maintained their balance on the ledge and
platform for significantly less time than control mice.pend on several skills, such as coordination, balance,
strength, or various somatosensory capabilities, the Similarly, although ataxia could account for these re-
sults, it is difficult to know the relative contributions ofmice were tested on a battery of four sensorimotor tests
(Wozniak et al., 1996). The performance of the potential disturbances in balance, coordination, and/or
strength to these performance deficits.Fgf14N--Gal/N--Gal mice and littermate controls on the in-
clined (60	) screen test showed that both groups were Group performance differences were also observed
on the walking initiation test, in which the Fgf14N--Gal/able to remain on the screen for the full 60 s trial period,
although the Fgf14N--Gal/N--Gal mice took significantly N--Gal mice showed a significant delay in the initiation
of movement (ambulation) out of the outlined squarelonger to climb to the top of the inclined screen (Figure
5C). The ability of the Fgf14N--Gal/N--Gal mice to remain on (Figure 5F). This is an interesting finding given that
Fgf14N--Gal/N--Gal and control mice were not found to differthe screen for the entire trial suggests that they were
not grossly impaired in muscle strength. However, this in terms of locomotor activity during a 1 hr testing ses-
sion. Even though the poor performance of Fgf14N--Gal/is a relatively insensitive measure of strength (Brosnan-
Watters et al., 1996). N--Gal mice on the ledge and platform tests may be ex-
plained in terms of ataxia, we cannot rule out modestThe finding that Fgf14N--Gal/N--Gal mice took longer than
controls to climb to the top of the inclined screen sug- deficits in muscle strength as a contributing factor.
At 1 month of age, Fgf14N--Gal/N--Gal mice developgested that the Fgf14N--Gal/N--Gal mice may have deficienc-
ies in coordination and/or strength. Pertinent to these paroxysmal forelimb clonic spasms with hyperextended
hindlimbs. The symptoms occur several times a dayfindings are the results of the inverted screen test (Figure
5C), which is considered to be a more conventional and last 7–12 min. Occasionally, episodes have been
observed to last 15–20 min. In young adults (1–3test of grip strength. Fgf14N--Gal/N--Gal mice were severely
impaired on this test and were able to remain on the months), the episodes can cause rearing with loss of
balance and forelimb tremor (see Supplemental Videoinverted screen for only a few seconds, whereas control
mice stayed on the screen for the entire length of the at http://www.neuron.org/cgi/content/full/35/1/25/
DC1). These symptoms are less severe in older mice (
3trial. These results suggest that the grip strength of the
Fgf14N--Gal/N--Gal mice was impaired, although distur- month). Because these episodes resembled seizures,
Fgf14N--Gal/N--Gal mice were monitored by electroenceph-bances in coordination could further contribute to their
Neurologic Defects in Fgf14 Knockout Mice
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Figure 4. Normal Brain Cytoarchitecture in
Fgf14N--Gal/N--Gal Mice
Coronal sections through striatum of the wild-
type (A and E) and Fgf14N--Gal/N--Gal (B and F)
mice, and through the cerebellum of the wild-
type (C and G) and Fgf14N--Gal/N--Gal (D and H)
mice at 3 months of age. Sections (A)–(D) are
stained with Luxol Fast blue to show axon
myelination. Sections (E)–(H) are stained with
silver to show the axon tracts. (I and J) Birth-
dating of wild-type (I) and Fgf14N--Gal/N--Gal (J)
mice that were labeled in utero with BrdU at
embryonic day 13.5 and examined at 1 month
of age for cells containing BrdU.
alography (EEG). No surface epileptiform EEG patterns (Figures 6D and 6E). The ventral striatum is involved
in regulating locomotor activity (Swanson et al., 1997).that correlated with the episodes of hyperkinetic move-
ment were observed (n  8 episodes in 4 different Examination of the levels of dopamine and its metabo-
lites 3,4-dihydroxyphenylacetic acid (DOPAC) and ho-Fgf14N--Gal/N--Gal mice; data not shown), suggesting that
these episodes were not seizures, but rather a move- movanillic acid (HVA) in this region demonstrated com-
parable levels in control and Fgf14N--Gal/N--Gal mice at 8ment disorder (paroxysmal dyskinesia). Several types
of paroxysmal dyskinesias have been documented in months of age (Figure 6F). Normal TH staining and DA
levels indicate that in Fgf14N--Gal/N--Gal mice, the dopa-both mouse and human, including paroxysmal kinesi-
genic choreoathetosis and paroxysmal dystonia (Bhatia, minergic neurons are structurally normal and produce
normal amounts of dopamine. This suggests that the1999; Vidailhet, 2000).
deficits in Fgf14N--Gal/N--Gal mice lie downstream of dopa-
minergic neurons.Integrity of Nigrostriatal Neurons and Expression
Both RNA blot (human brain) and in situ hybridizationof Fgf14N--Gal in Striatonigral Pathways
(mouse brain) failed to detect Fgf14 (or -gal) mRNAIt has been suggested that both hyperkinetic and hypo-
expression in the substantia nigra (Figure 2). In contrast,kinetic movement disorders can be caused by lesions
staining for FGF14N--gal protein showed intense activ-in the basal ganglia. This prompted us to examine the
ity in the striatum, globus pallidus, and substantia nigra.neural pathways of the basal ganglia in Fgf14N--Gal/N--Gal
Comparison of TH and FGF14N--gal staining patternsmice.
in comparable sections of the substantia nigra (FiguresThe basal ganglia system contains feedback circuitry
6A–6C) showed mutually exclusive expression, withthat includes dopaminergic nigrostriatal neurons and
FGF14N--gal protein present in the substantia nigraGABAergic striatonigral and striatopallidal neurons.
pars reticulata (SNr) and TH in the SNc. Taken together,Neuromuscular diseases, such as Parkinson’s disease,
these data indicate that Fgf14N--Gal is not expressed byoften involve degeneration of dopaminergic nigrostriatal
dopaminergic neurons, but is expressed in the axonsneurons that project from the substantia nigra pars com-
of either or both the striatopallidal or striatonigralpacta (SNc) to the striatum (Dawson, 2000; Smith and
pathways.Kieval, 2000). Immunostaining for tyrosine hydroxylase
(TH), the rate-limiting enzyme in dopamine synthesis,
revealed normal-appearing dopaminergic neurons in the Fgf14N--Gal/N--Gal Mice Show Abnormal Responses
to Dopamine AgonistsSNc and the ventral tegmental area (VTA) (Figures 6A
and 6B) at 2.5 months of age, suggesting no degenera- Studies of a rodent model of paroxysmal dystonia indi-
cated that a functional, rather than an anatomical, distur-tion of dopaminergic neurons. Normal TH staining inten-
sity in the striatum suggested that axonal projections bance in the basal ganglion system may be the primary
etiology of the neuropathology (Gernert et al., 2000; No-of dopaminergic neurons to the striatum were also intact
Neuron
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Figure 5. Sensorimotor Evaluation of Fgf14N--Gal/N--Gal Mice
(A) Gait analysis showing forefoot-hindfoot correspondence in a wild-type (/) mouse and lack of forefoot-hindfoot correspondence in an
Fgf14N--Gal/N--Gal (/) mouse. (B) Rotorod evaluation of wild-type (n  6) and Fgf14N--Gal/N--Gal mice (n  10) (mixed 129SV/J/C57B6/J genetic
background). Fgf14N--Gal/N--Gal mice were unable to improve performance over the trial period (p  0.001). (C) Screen grip test. Mice were
placed on a 60	 inclined screen. Solid bars represent time on the screen (60 s maximum). Open bars represent the elapsed time for mice to
climb to the top of the screen. Gray bars represent the elapsed time that mice were able to remain on an inverted screen (60 s maximum).
Wild-type mice (n  9), Fgf14N--Gal/N--Gal mice (n  8). (D) Platform test and (E) ledge test measure the elapsed time that mice maintain balance
on a small platform or ledge. (F) Walk initiation test. (D–F) Open bar represents wild-type mice (n  9), solid bar represents Fgf14N--Gal/N--Gal
mice (n  8). All data are expressed as the mean  SEM. Asterisks indicate significant difference between / and / groups (Student’s
t test). *p  0.05, **p  0.01, ***p  0.001.
brega et al., 1996; Rehders et al., 2000). Prominent ex- plays a critical role in the hyperactivity response of mice
treated with psychostimulants, and dopamine D1 recep-pression of FGF14 in the basal ganglia system and the
importance of this part of the brain in regulating move- tor-deficient mice completely lack a locomotor response
to cocaine (Xu et al., 1994). In addition, dopamine D1ment suggested that Fgf14N--Gal/N--Gal mice could have
an aberrant response to dopaminergic agonists. Dopa- receptor-deficient mice are nonresponsive to 2 mg/kg
amphetamine and show a decreased response to 5 mg/minergic pathways can be activated by psychostimu-
lants, such as cocaine and amphetamine. Both drugs kg of amphetamine (Xu et al., 2000). Amphetamine ap-
pears to be more potent than cocaine in increasing ex-increase the level of synaptic dopamine and result in
hyperactivity in the mouse, rat, and human. To examine tracellular dopamine concentration (Akimoto et al., 1990;
Butcher et al., 1988). The differential response to co-the functional integrity of the basal ganglia system, loco-
motor activity was monitored in Fgf14N--Gal/N--Gal mice caine and amphetamine likely reflects the amount of DA
released in the striatum and indicates that Fgf14N--Gal/that were challenged with cocaine, amphetamine, and
specific dopamine receptor agonists. At a dosage of 10 N--Gal mice are unresponsive to small increases in extra-
cellular dopamine induced by cocaine, but are able tomg/kg, cocaine failed to induce locomotor hyperactivity
in 9- to 12-month-old male Fgf14N--Gal/N--Gal mice (p  respond (to a lesser degree) to high concentrations of
dopamine induced by amphetamine. The decreased re-0.01) (Figure 7A), while causing a significant hyperactiv-
ity response in wild-type littermates. The hyperactivity sponse to psychostimulants in Fgf14N--Gal/N--Gal and
D1R/ mice likely reflects diminished signaling throughresponse to amphetamine at doses of 2 and 4 mg/kg
was significantly lower in Fgf14N--Gal/N--Gal mice than in the stimulatory dopamine D1 receptor-containing neu-
rons (striatonigral pathway). This hypothesis is furtherthe wild-type littermates (p  0.01) (Figure 7A).
The biological actions of the neurotransmitter dopa- supported by the small decrease in the hyperactivity
response induced by the D1 receptor-specific agonistmine are mediated by two classes of receptor, the D1
(D1 and D5) class and the D2 (D2, D3, and D4) class SKF38393 in Fgf14N--Gal/N--Gal mice compared to that of
wild-type mice (p  0.12) (Figure 7B).(Missale et al., 1998). Dopamine D1 receptor signaling
Neurologic Defects in Fgf14 Knockout Mice
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Figure 6. Integrity of Dopaminergic Neurons
in the Substantia Nigra and Striatum and Do-
pamine/Dopamine Metabolite Levels in the
Ventral Striatum
(A and B) Tyrosine hydroxylase (TH) staining
in the substantia nigra pars compacta (SNc)
and ventral tegmental area showing similar
staining patterns in wild-type (/) and
Fgf14N--Gal/N--Gal (/) mice.
(C) X-gal staining of a Fgf14N--Gal/N--Gal brain
section showing FGF14N--gal localization in
the substantia nigra pars reticulata (SNr).
(D and E) TH staining in the caudate putamen
(CPu) showing similar staining patterns in
wild-type (D) and Fgf14N--Gal/N--Gal (E) mice.
(F) Levels of dopamine (DA) and dopamine
metabolites 3,4-dihydroxyphenylacetic acid
(DOPAC) and Homovanillic acid (HVA) in the
ventral striatum.
D1 and D2 receptors appear to be largely segregated Activation of presynaptic D2 receptors results in de-
creased DA release and, thus, decreased locomotor ac-in different neuronal populations, and only 20%–25% of
neurons express both receptors (Surmeier et al., 1998). tivity, whereas activation of postsynaptic D2 receptors
Figure 7. Locomotor Activity Response to
Stimulant Drugs and Dopamine Receptor Ag-
onists
(A) Cohorts of wild-type (n  9, open bars)
and Fgf14N--Gal/N--Gal mice (n  14, solid bars)
were treated with saline, cocaine (10 mg/kg),
or amphetamine (2 and 4 mg/kg) and assayed
for locomotor activity. Fgf14N--Gal/N--Gal mice
showed no locomotor response to 10 mg/kg
cocaine (p  .006 relative to / mice) and
had a reduced locomotor response to both
doses of d-amphetamine (p  0.01 relative
to / mice).
(B) The same cohorts of mice were treated
with saline, the D1 receptor agonist SK38393,
or the D2 receptor agonist quinpirole.
Fgf14N--Gal/N--Gal mice lacked a hypolocomotor
response to the D2 agonist, quinpirole (p 
0.0002 relative to / mice). There was a
slight trend toward a significant difference
(p  .12) between the groups after injection
of the D1 agonist, SKF38393. All data are ex-
pressed as the mean  SEM. **p  0.01,
***p  0.001.
Neuron
32
(striatopallidal pathway) results in a small increase in
locomotor activity. Quinpirole is a D2-class receptor ag-
onist that can have biphasic effects on locomotor activ-
ity in rats (Frantz and Van Hartesveldt, 1999). In mice,
a dose of 0.5 mg/kg has been shown to decrease loco-
motor activity (Geter-Douglass et al., 1997). Consistent
with these results, quinpirole, at a dose of 0.5 mg/kg,
caused a 4.5-fold decrease in locomotor activity in wild-
type mice (Figure 7B). In contrast, Fgf14N--Gal/N--Gal mice
showed no significant response to quinpirole (p 0.001)
(Figure 7B). The lack of response to quinpirole suggests
that the D2 receptor-mediated signaling is impaired in
Fgf14N--Gal/N--Gal mice.
Reduced Cocaine Induced Striatal c-fos
Activation in FGF14-Deficient Mice
In addition to its acute effect on locomotor behavior,
cocaine has a potent effect on gene expression in the
striatum (Graybiel et al., 1990). Activated dopamine re-
ceptors trigger a series of second messenger cascades
that result in the expression and activation of immediate-
early genes, such as c-fos (Moratalla et al., 1996a). D1
and D2 receptors have different roles in c-fos induction
(Alonso et al., 1999; Le Moine et al., 1997; Robertson
and Jian, 1995). Activation of D1 receptors upregulates
c-fos expression in the striatum. Activation of D2 recep-
tors downregulates the basal expression of c-fos in the
striatum, but paradoxically increases c-fos expression
in the globus pallidus. The optimal dose of cocaine for
c-fos induction in mice is 40 mg/kg (Moratalla et al.,
1996b). At this dose, cocaine robustly induced c-fos
expression in the striatum of wild-type mice after 2 hr
(Figures 8A, 8C, and 8E). In contrast, in Fgf14N--Gal/N--Gal
mice, striatal c-fos induction was dramatically reduced
(Figures 8B, 8D, and 8E) even though tonic seizures were
triggered (see below). The difference in c-fos induction
between wild-type and Fgf14N--Gal/N--Gal mice is unlikely
to be a consequence of the seizure activity, because
seizure activity induced c-fos expression in multiple
brain regions including hippocampus, olfactory bulb,
and cerebellum. Also, cocaine-induced c-fos expression
Figure 8. Induction of c-Fos Nuclear Localization in Response toin the striatum is largely independent of the onset of
Cocaineseizures (Clark et al., 1992). These data suggest that
Immunohistochemical detection of c-Fos in wild-type (A and C) andlack of FGF14 specifically impairs immediate-early gene
Fgf14N--Gal/N--Gal (B and D) brain tissue 2 hr following intraperitoneal
induction in response to cocaine in striatal neurons. injection of either saline (A and B) or cocaine (40 mg/kg) (C and D).
Following cocaine injection, Fgf14N--Gal/N--Gal mice showed dimin-
ished levels of c-Fos expression compared to control mice. (E) Quan-Fgf14N--Gal/N--Gal Mice Have a Reduced Threshold
tification of c-Fos-labeled nuclei in the dorsal striatum. After cocaineto Seizure Induced by Cocaine and PTZ
induction, the number of c-Fos-positive nuclei in Fgf14N--Gal/N--GalHigh doses of cocaine commonly result in epileptic sei-
striatum was significantly lower than that of wild-type controls; *pzure. Activation of dopamine receptors plays a key role 0.02 (n  3 for wild-type treated with PBS or cocaine and for
in the initiation of cocaine-induced seizure. Dopamine Fgf14N--Gal/N--Gal treated with cocaine, n  2 for Fgf14N--Gal/N--Gal
D1 receptors have a proconvulsive effect, whereas D2 treated with PBS). Data are expressed as the mean  SEM. Open
bars are wild-type controls, solid bars are Fgf14N--Gal/N--Gal mice. CC,receptors have an anticonvulsive effect (Ushijima et al.,
corpus callosum; CPu, caudate-putamen; CT, cerebral cortex; S,1995; Waddington, 1993). In wild-type mice (n  10),
septum.injection of cocaine (40 mg/kg) did not induce seizures.
In contrast, injection of Fgf14N--Gal/N--Gal mice with 40 mg/
kg cocaine resulted in brief tonic movements, mostly in epileptiform spikes in their EEG recordings (Figures 9E
and 9F). The EEG changes at 40 mg/kg of cocaine indi-the hindlimbs, followed by a period of immobility (n 
9 of 9 mice tested). EEG recordings showed epileptiform cate that the cerebral cortex of Fgf14N--Gal/N--Gal mice may
be in a hyperexcitable state.activity associated with the seizure-like symptoms (Fig-
ures 9A–9D) (n  3 per genotype). At 80 mg/kg cocaine, To determine whether the reduced seizure threshold
is restricted to increased sensitivity to cocaine versusboth wild-type mice (n  2) and FGF14-deficient mice
(n  2) developed tonic-clonic seizures with associated resulting from a more widespread affect on cortical hy-
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Figure 9. Cocaine and PTZ Induced Seizure
Activity
(A and B) Baseline EEG recordings for wild-
type and Fgf14N--Gal/N--Gal mice.
(C and D) EEG recordings following injection
of 40 mg/kg cocaine showing epileptiform ac-
tivity in Fgf14N--Gal/N--Gal mice.
(E and F) EEG recordings following injection
of 80 mg/kg cocaine showing epileptiform ac-
tivity in both wild-type and Fgf14N--Gal/N--Gal
mice.
(G) Latency to onset of tonic-clonic seizure
following i.p. injection of PTZ (100 mg/kg).
Data are plotted as the mean  SEM; n  8,
**p  0.003.
(H and I) ERK activation in response to treat-
ment with PTZ. (H) Western blot detection
of p44/42 MAPK (ERK) and phospho-ERK in
wild-type (/) and Fgf14N--Gal/N--Gal (/) ce-
rebral hemispheres following intraperitoneal
injection of PTZ. (I) Quantification of the ratios
of the band intensities of p-ERK and total
ERK shown in (H) and in additional data not
shown. The ratio in wild-type mice was arbi-
trarily normalized to 1. No significant differ-
ence in ERK activation was observed in the
cerebral hemispheres of wild-type (open
bars) and Fgf14N--Gal/N--Gal (solid bars) mice in-
jected with saline (n  4 of each genotype).
However, following treatment with PTZ,
Fgf14N--Gal/N--Gal mice showed significantly
higher levels of p-ERK compared to littermate
controls. Data are plotted as the meanSEM
(n  7 of each genotype, *p  0.04).
persensitivity, FGF14-deficient mice and their wild-type ally with PBS or with 75 mg/kg of pentylenetetrazol
(PTZ). Brain tissue was harvested 90 s after injection,littermates were treated with pentylenetetrazol (PTZ), a
drug commonly used to induce experimental seizure in divided into cerebellar and cortical hemispheres, and
homogenized. ERK and phospho-ERK were detectedrodents (Fisher, 1989). At both 75 mg/kg and 100 mg/
kg, FGF14-deficient mice showed a significantly shorter by immunoblotting. Fgf14N--Gal/N--Gal mice and wild-type
littermates showed similar levels of ERK and phospho-latency to PTZ-induced seizure (Figure 9G, and data not
shown). ERK following injection with PBS in both cerebellar (data
not shown) and cerebral hemispheres (Figure 9H). In
contrast, following treatment with PTZ, the relative levelElevated ERK Activation in Response to PTZ
Treatment in FGF14-Deficient Mice of phospho-ERK was elevated 2-fold (n  7, p  0.036)
in cerebral hemispheres of Fgf14N--Gal/N--Gal mice, but notFgf14 is a member of a subfamily of four related genes,
Fgfs 11–14. The closely related family member, FGF12, in wild-type mice (Figure 9I). No change in ERK activa-
tion was observed in the cerebellum following treatmentinteracts with the MAP kinase scaffold protein, islet-
brain-2 (IB2). Interestingly, in the absence of FGF12, IB2 with PTZ (data not shown).
does not bind to any MAP kinase tested, but in the
presence of FGF12, IB2 efficiently binds p38, sug- Discussion
gesting that FGF12 has a role in modulating MAP kinase
signaling pathways (Schoorlemmer and Goldfarb, 2001). FGF14 is widely expressed in the developing CNS and
in the adult brain. To determine the role of FGF14 inBinding experiments demonstrate that FGF14 also inter-
acts with IB2 (Q.W., D.M.O., M. Goldfarb, unpublished CNS development and in adult brain function, we have
disrupted the Fgf14 gene by homologous recombinationdata), suggesting that FGF14 may also regulate the as-
sociation of specific MAP kinases with IB2. To determine and inserted the -gal cDNA in frame into exon 2. Al-
though the Fgf14N--Gal mRNA is expressed in the correctwhether the level of ERK activation is altered in
Fgf14N--Gal/N--Gal mice, we examined ERK and phospho- regions of the brain, the FGF14N--gal protein is traf-
ficked into axonal processes and thus is present inERK levels in the brains of Fgf14N--Gal/N--Gal mice and their
wild-type littermates. Mice were injected intraperitone- places where the mRNA is not expressed. Fgf14N--Gal/
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Figure 10. Schematic Diagram Showing
Basal-Ganglia-Thalamocortical Circuitry un-
der Normal Conditions and in Fgf14N--Gal/N--Gal
Mice
(A) Wild-type mice.
(B) Fgf14N--Gal/N--Gal mice. Fgf14N--Gal/N--Gal mice
appear to have an imbalance between the
striatonigral (D1R) and striatopallidal (D2R)
signaling pathways, resulting in increased
thalamocortical output. The green lines rep-
resent the excitatory neuronal projections,
and the red lines represent inhibitory projec-
tions. The widths of the lines represent rela-
tive intensity of signaling. The black arrows,↑
or ↓, indicate pathways that are either hypoac-
tive or hyperactive in Fgf14N--Gal/N--Gal mice.
CPu, caudate-putamen (striatum); GPi, glo-
bus pallidus internal segment; GPe, globus
pallidus external segment; PPN, pedunculo-
pontine nucleus; STN, subthalamic nucleus;
SNc, substantia nigra pars compacta; SNr,
substantia nigra pars reticulata; Thal,
thalamus.
N--Gal mice are viable, fertile, and histologically normal, drug-naive mice, quinpirole elicits a dose-dependent
decrease in locomotor activity at a dosage between 0.03but develop severe ataxia and paroxysmal dyskinesia.
and 2.0 mg/kg (Chen et al., 2000; Geter-Douglass et al.,
1997; Jones et al., 1999; Wang et al., 2000b). WhileBasal Ganglia Thalamocortical Circuitry
0.5 mg/kg quinpirole caused an 4.5-fold decrease inin Fgf14N--Gal/N--Gal Mice
locomotor activity in wild-type mice, 0.5 or 2 mg/kgIn current models of basal ganglia circuitry (Figure 10A),
quinpirole failed to cause locomotor depression inthe striatum (caudate-putamen, CPu) receives input
Fgf14N--Gal/N--Gal mice. Locomotor depression in re-from the cerebral cortex and projects through two path-
sponse to quinpirole can be explained by a predominantways to the SNr and the internal segment of the globus
effect on presynaptic activity in the striatonigral pathwaypallidus (Gpi) (Todd and Perlmutter, 1998). Neurons in
(decreased synaptic dopamine) and postsynaptic activ-the striatonigral pathway express D1 class dopamine
ity in the striatopallidal pathway (Figure 10A). Becausereceptors (D1R) and provide inhibitory input to the Gpi/
net locomotor activity depends on the integration func-SNr. Striatopallidal neurons primarily express D2 class
tion of the SNr, it appears that the striatopallidal pathway
dopamine receptors (D2R) and provide net excitatory
is more severely affected than the striatonigral pathway
input to the Gpi/SNr via inhibitory projections to the
in Fgf14N--Gal/N--Gal mice (Figure 10B).
external segment of the globus pallidus (Gpe) and sub- These experiments clearly show functional defects in
thalamic nucleus (STN). Dopaminergic neurons pro- both the D1 receptor-mediated striatonigral pathway
jecting to both the striatonigral and striatopallidal path- and the D2 receptor-mediated striatopallidal pathway.
ways express presynaptic D2 receptors which inhibit The D1R- and D2R-expressing neurons in both path-
DA release (Missale et al., 1998). The Gpi/SNr integrates ways are primarily GABAergic (Graybiel, 1990). Because
input from these pathways and provides an inhibitory FGF14 is most likely localized in axons, the observed
signal to the thalamus. The balance of the net input from phenotype may actually result from defects in GABA-
these two pathways is critical for the planning, initiation, mediated synaptic transmission or some aspect of axo-
and execution of movements (Obeso et al., 2000; Todd nal function such as vesicle trafficking.
and Perlmutter, 1998; Vitek and Giroux, 2000; Wichmann
and DeLong, 1996). Human movement disorders such Cortical Hyperexcitability in Fgf14N--Gal/N--Gal Mice
as Parkinson’s disease, Huntington’s diseases, and dys- We observed paroxysmal hyperkinetic episodes in
tonia are caused by brain lesions that effectively disrupt Fgf14N--Gal/N--Gal mice. Because the striatonigral and stri-
the balance between these pathways. atopallidal pathways are affected to different degrees
Both the striatonigral and striatopallidal pathways ap- in Fgf14N--Gal/N--Gal mice, we posit that the net effect is a
pear to be affected in Fgf14N--Gal/N--Gal mice. reduction in excitatory stimulus to the GPi/SNr, subse-
Fgf14N--Gal/N--Gal mice have reduced locomotor hyperac- quent decreased inhibitory input to the thalamus, and
tivity in response to elevated synaptic dopamine levels increased excitatory stimulus to the motor cortex (Figure
induced by cocaine and amphetamine, indicating dys- 10B). Enhanced cortical excitability in Fgf14N--Gal/N--Gal
function of striatonigral pathway. In wild-type mice, this mice is supported by the increased sensitivity to co-
hyperactivity response is mediated by striatonigral caine- and PTZ-induced seizures. The cortical hyperac-
(D1R) activity in synergy with striatopallidal (postsynap- tivity in Fgf14N--Gal/N--Gal mice resembles hyperkinetic
tic D2R) activity (Figure 10B) (Gershanik et al., 1983; movement disorders in humans such as Huntington’s
Jackson and Westlind-Danielsson, 1994; Missale et al., disease, L-dopa-induced dyskinesia in Parkinson’s dis-
1998). Pharmacologic evidence also demonstrates dys- ease, and dystonia (Obeso et al., 2000; Vitek and Giroux,
2000; Wichmann and DeLong, 1996).function in striatopallidal (D2R) mediated signaling. In
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Fgf14N--Gal/N--Gal Mice Model Paroxysmal Dystonia Molecular Function of FGF14
The data presented here and in several recent publica-Dystonia is a heterogeneous group of syndromes that
may have etiologies in a variety of neuronal pathways. tions suggest that FGF14 is important for axonal func-
tion, synaptosomal function, or neurotransmission. HereAlthough an imbalance in striatonigral and striatopallidal
pathways is sufficient to trigger dystonic episodes in we demonstrate neurological defects in mice lacking
FGF14. We also show that 70 amino acids, encodedhumans and rodents, pathology in other parts of the
brain can also cause dystonia (Jarman and Warner, by exon 1b, are sufficient to efficiently target the -gal
protein into axonal projections. These observations1998; Richter and Loscher, 1998). Because FGF14 is
expressed prominently in cerebellar granule cells, it is demonstrate neuronal function for FGF14 and suggest
that FGF14 itself is localized in axonal projections andpossible that dysfunction of the cerebellum also contrib-
utes to both the dystonia and the ataxia phenotypes. may therefore function in these locations.
FGF12 (Goldfarb, 2001; Schoorlemmer and Goldfarb,The episodic nature of the involuntary movement phe-
notype in Fgf14N--Gal/N--Gal mice is similar to the pheno- 2001) and FGF14 interact with the MAP kinase scaffold
protein IB2. Together with our in vivo data showing in-type of the dystonic hamster (dtsz), the only rodent ge-
netic model of primary paroxysmal dystonia (Loscher et creased activation of ERK following treatment with PTZ,
these data provide strong support for the regulation ofal., 1989). The mutation in the dtsz hamster is autosomal
recessive and the gene has not been identified. As in intracellular signaling pathways in neurons by FGF12
and FGF14. Increased ERK activation in Fgf14N--Gal/N--Galthe dtsz hamster, bilateral EEG recordings before and
during the dystonic episodes in Fgf14N--Gal/N--Gal mice did mice suggests that endogenous FGF14 acts to nega-
tively regulate ERK activation. Interestingly, overexpres-not reveal any epileptiform abnormalities, despite the
generalized motor involvement. Dystonic events in the sion of IB1 or IB2 potently inhibits JNK signaling path-
ways (Dickens et al., 1997; Yasuda et al., 1999). Recently,dtsz hamster can initiate spontaneously or be induced
by mild stressful stimuli. The severity of each event is a computational model for the interaction of scaffold
proteins and MAP kinases shows that the scaffold pro-variable but can be categorized into six stages (Rehders
et al., 2000). The most frequently observed phenotypes teins could either positively or negatively regulate MAP
kinase pathways, depending on precise protein concen-in Fgf14N--Gal/N--Gal mice correspond to the third and
fourth stages in the dtsz hamster, in which the animals trations (Levchenko et al., 2000). Furthermore, it is inter-
esting that IB1 and IB2, like FGF14, are expressed in ahave hyperextended hindlimbs, twisting movements,
and a loss of balance. Unlike in the dtsz hamster, the wide range of neuronal tissues (Yasuda et al., 1999). IB1
and IB2 are colocalized to cell surface projections of andystonic episodes in Fgf14N--Gal/N--Gal mice are often ac-
companied by forelimb tremor. Increased net inhibitory insulinoma cell line (Yasuda et al., 1999). Additionally,
brain immunohistochemistry localized IB1 in neuronalstriatal output (decreased inhibitory signals to the thala-
mus) has been suggested as an etiology of the paroxys- processes (Pellet et al., 2000). It is therefore likely that
FGF14 and IB2 interact within neurons and that the ratiomal dystonia in the dtsz hamster (Nobrega et al., 1996,
1999; Rehders et al., 2000), similar to that postulated of the concentration of these two proteins could modu-
for Fgf14N--Gal/N--Gal mice. The latency of the dystonic late specific MAP kinase-signaling pathways.
attacks in the dtsz hamster is significantly reduced by Several studies have addressed the regulation of pre-
subconvulsive doses of PTZ (Loscher et al., 1989), sug- synaptic signaling by phosphorylation through the MAP
gesting that the cortex of the dtsz hamster is at a higher kinase pathway. Synapsins, regulating synaptic vesicle
level of excitability. release (Greengard et al., 1993; Li et al., 1995), are regu-
lated by MAP kinase phosphorylation (Jovanovic et al.,
1996), and Synapsin 1 is the major substrate for MAPLack of c-fos Induction by Cocaine
in Fgf14N--Gal/N--Gal Mice kinase in rat cerebral cortex (Jovanovic et al., 2000).
Phosphorylation regulates the association of synapsinsImmediate-early gene expression in the striatum can
be induced by psychostimulants, such as cocaine and with the actin cytoskeleton. In a recent paper, MAP ki-
nase-dependent regulation of synapsin 1 phosphoryla-amphetamine (Graybiel et al., 1990), and by the neuro-
leptic drugs, haloperidol and raclopride (Robertson and tion was shown to potentiate glutamate release. In this
study, MAP kinase was activated by treatment withJian, 1995). These drugs have opposite effects on loco-
motor activity, indicating that the c-fos induction is not BDNF (Jovanovic et al., 2000). Interestingly, mice lacking
Synapsin 1 were predisposed to develop seizures (Li etdirectly correlated to the increased locomotor activity.
The expression of c-fos in the striatum is upregulated al., 1995).
A second relevant observation identified an interac-by D1 receptor activation and downregulated by D2
receptor activation (Keefe and Gerfen, 1995). Paradoxi- tion between IB2 and the carboxy-terminal domain of
kinesin (Verhey et al., 2001). These data suggest thatcally, activation of both D1 and D2 receptors has a syner-
gistic effect on c-fos induction (Keefe and Gerfen, 1995). IB2, and therefore FGF12 and FGF14, may be kinesin
cargo, transported down axons by kinesin motors. How-The loss of c-fos induction in the striatum in
Fgf14N--Gal/N--Gal mice likely reflects diminished signaling ever, the amino-terminal peptide (exon 1b), axonal traf-
ficking signal of FGF14 is distinct from the IB2 bindingthrough both the striatonigral and striatopallidal path-
ways and possibly loss of synergy between them. The domains and therefore may have a unique role in FGF14
axonal trafficking. Further investigation will be requiredimmediate-early gene c-fos is involved in transcriptional
regulation of many genes. Thus, decreased c-fos induc- to determine the relationship between kinesin and the
amino terminus of FGF14. It will also be important totion in the absence of FGF14 may reflect changes in
neuronal gene expression, which may in turn alter neu- determine whether FGF14 is a kinesin cargo molecule
and, therefore, functioning at or beyond the nerve termi-ronal function.
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sponding areas were counted from the region just under the corpusnus or, alternatively, is involved in regulating axonal
callosum. p values were calculated using the Student’s t test fortransport.
independent samples (Statview software).
Experimental Procedures
Sensorimotor Tests
The sensorimotor battery included the inclined screen, platform,Gene Targeting and Generation of FGF14-Deficient Mice
ledge, and walking initiation tests performed as described byThe targeting vector (Figure 1A) was designed to delete exon 2 (after
Schaefer et al. (2000). For the inverted screen test, mice were placedthe fifth codon), the entire exon 3, and the 3 kb intron between exon
on the screen, and then the screen was inverted to 180	. A maximum2 and exon 3. A -gal gene was inserted in frame with the fifth
score of 60 s was given if an animal did not fall. For the rotorodcodon of exon 2. The targeting vector contains 4.5 kb of 5 homolo-
(Columbus Instruments) test, each mouse was placed on a station-gous genomic DNA and 2.7 kb of 3 homologous genomic DNA
ary rotorod and then on a rotating rotorod at a constant speed (5flanking the deletion. The Neo selection cassette was cloned down-
rpm). Once each mouse was able to maintain balance for 1 min onstream of the inserted -gal gene and is flanked by two loxP sites
three consecutive trials, it proceeded to the next training step. Afterwhich can be used for cre-mediated excision. The targeting vector
successful completion of the training, each mouse was tested onwas also flanked by two TK genes. The plasmid was linearized with
the accelerating rotorod (5–20 rpm over 0–180 s) for three trials perSfi1, electroporated into SM1 embryonic stem (ES) cells (gift from
day for 5 consecutive days. The mean latency to fall off the rotorodR. Hammer), and selected with G418 and FIAU. Genomic DNA was
was recorded.isolated from ES cells, digested with EcoRI, and hybridized with a
For locomotor activity experiments, all mice were acclimated to5 external probe (400 bp PCR fragment) (Figure 1B) or digested
the activity cages (28 cm long  17 cm wide  12.5 cm high) for 1with EcoRV and hybridized to a 3 external probe (700 bp XbaI
hr on 2 consecutive days. For each drug experiment, animals werefragment). Two correctly targeted clones were identified out of two
placed in the activity cages for 30 min before receiving an intraperi-hundred ES cell colonies surviving selection with G418 and FIAU.
toneal injection (10 mg/kg cocaine hydrochloride [Sigma], or 20 mg/These clones were individually injected into blastocysts derived
kg SKF38393 [RBI, Natik, MA]) or a subcutaneous injection (2.0 orfrom C57BJ/6 mice. Both clones gave rise to chimeric mice that
4.0 mg/kg d-amphetamine sulfate [Sigma], or 2.0 mg/kg quinpiroletransmitted the targeted allele into the germline.
[RBI, Natik, MA]). Animals were then placed back into the activityGenotyping of progeny was by Southern blot (as described above)
cages for 55 min. Mice were tested every other day and the order ofor by PCR analysis of tail DNA. The 5 primer, QW127 (5-CTAGTTT
drug treatment was counterbalanced across days within genotypeCATGAAATCCCTATTTC-3), hybridizes to the 5 homologous re-
groups. Locomotor activity was recorded every 5 min by two beamsgion. The 3 primers were QW128 (5-GCCTTGCCTGCAATATAACC
of red light placed at 10 and 19 cm along the length of the activityTGGTCAC-3), hybridizing to Fgf14 exon 2 for the wild-type allele,
cage.and QW129 (5-CGCTATTACGCCAGCTGGCGAAAG-3), which hy-
Statistical Analysesbridizes to the 5 region of the -gal cDNA. PCR conditions were:
The behavioral data were analyzed using analysis of variance30 cycles (95	C for 30 s, 55	C for 1 min, 72	C for 1 min) followed by
(ANOVA) models typically containing one between-subjects variable3 min at 72	C. The PCR assay generated a 255 bp fragment for
(genotype) and one within-subjects variable (e.g., trials or test Ses-the wild-type allele and a 350 bp fragment for the Fgf14N--Gal allele
sions). Subsequent one-way ANOVAs were used to evaluate main(Figure 1C).
effects. Data from the experiments concerning drug effects on loco-
motor activity were analyzed by using a two-way ANOVA with oneRNA Blot Hybridization
between-subjects variable (drug) being added to the above model.RNA was isolated from the cerebellum of 21-day-old mice using the
Fisher’s protected least squares difference tests were used for dataRNeasy kit (Qiagen, Almeda, CA). A 315 bp Fgf14 probe derived
involving post hoc comparisons of individual groups. Alpha was setfrom exon 2, exon 3, and a part of exon 4 was hybridized to a mouse
at p  0.05 for all analyses.cerebellar RNA blot or to a human brain RNA blot (Clonetech Inc.)
Band intensity was quantified by scanning densitometry using NIH
Measurement of Dopamine and Its Metabolitesimage software.
Tissue concentrations of dopamine and dopamine metabolites (DO-
PAC and HVA) were measured by HPLC coupled with electrochemi-In Situ Hybridization
cal detection as previously described (Bardgett et al., 1997). A 2Brain tissues were harvested from 30-day-old mice that were per-
mm coronal slice of each mouse brain containing the nucleus ac-fused with 4% paraformaldehyde. Hybridization and tissue pro-
cumbens and dorsal striatum was isolated with a razor blade. Thecessing were performed as described previously (Wang et al.,
nucleus accumbens was microdissected with a 1.6 mm cold stain-2000a).
less steel tube, which contained a stylet for punch removal. Punches
from the left and right nucleus accumbens were combined in 1.5Staining for -Galactosidase Activity
ml polypropylene tubes, placed on dry ice, and stored at 80	CFGF14N--gal and -gal enzymatic activity was localized in situ by
until assayed. Dopamine, DOPAC, and HVA were detected by HPLCstaining with 5-bromo-4-chloro-3-indolyl--d-galactoside (X-gal).
using an ESA 5020 guard cell and an ESA 7013 dual electrodeThree-month-old mice were perfused with 2% paraformaldehyde.
analytical cell coupled to ESA Coulochem II detector. All valuesBrains were harvested and embedded in OCT compound and cryo-
were derived and analyzed from standard curves for DA, DOPAC,stat sectioned at20	C. Subsequently, sections were stained in 0.1
and HVA using a computerized data analysis program (BechmannM sodium phosphate (pH 7.0), 2 mM MgCl2, 5 mM K3Fe(CN)6, 0.01%
System Gold).sodium deoxycholate, 0.02% NP-40, 20 mM Tris-HCl, and 1 mg/ml
of X-gal at 37	C overnight. Slides were then counter-stained with
nuclear fast red. Pentylenetetrazol Treatment and ERK Activation Analysis
Pentylenetetrazol (Sigma) was dissolved in saline (10 mg/ml) and
injected intraperitonealy at a dose of either 75 or 100 mg/kg. TimeHistology and Immunohistochemistry
Nissl, Luxol Fast Blue, and silver stains were carried out according to onset of tonic-clonic seizure was recorded. In the first experiment
(shown), the mean age was 82 days and the sex ratio was 50%to Sheehan and Hrapchak (1980). Immunohistochemistry used anti-
c-Fos antibody (1:30,000; Oncogene Science, Inc.) or anti-tyrosine male/female. In the second experiment (data not shown), the mean
age was 354 days and all animals were female.hydroxylase antibody (1: 1,000; Chemicon International, Inc). Sec-
tions were visualized using the Vectastain ABC kit (Vector Labora- For ERK activation, adult (6–23 weeks) Fgf14N--Gal/N--Gal and wild-
type female mice were injected intraperitonealy with 75 mg/kg PTZtories). BrdU immunohistochemistry was performed as described
previously (Naski et al., 1998). or PBS. On each of 3 days prior to the day of the experiment, each
mouse was twice injected intraperitoneally with PBS to habituateQuantification of c-Fos Stained Nuclei
Images from the dorsal-medial striatum containing c-Fos-immuno- the animals to handling and injections. The animals were sacrificed
90 s after the experimental injection (or at the onset of status epilep-reactive nuclei were captured through a 10 objective lens. Corre-
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ticus). The cerebral hemisphere and cerebellum were removed and (2000). Selective attenuation of psychostimulant-induced behavioral
responses in mice lacking A(2A) adenosine receptors. Neurosciencehomogenized in 500 l of boiling lysis buffer (1% SDS, 20 l/ml
protease inhibitor cocktail solution [Sigma P8340], and 1 mM sodium 97, 195–204.
ortho-vanadate). Protein levels in supernatants were determined by Clark, M., Post, R.M., Weiss, S.R., and Nakajima, T. (1992). Expres-
the Bradford method using a protein assay kit (Bio-Rad, Hercules, sion of c-fos mRNA in acute and kindled cocaine seizures in rats.
CA). Aliquots of each sample containing 20 g of protein were elec- Brain Res. 582, 101–106.
trophoresed on precast 12% Tris-HCl polyacrylamide gels (Bio- Dawson, T.M. (2000). New animal models for Parkinson’s disease.
Rad). Proteins were visualized with a polyclonal rabbit anti-phos- Cell 101, 115–118.
pho-p44/42 MAPK (ERK) antibody (1:1000; Cell Signaling, Beverly,
Dickens, M., Rogers, J.S., Cavanagh, J., Raitano, A., Xia, Z., Halpern,MA) or polyclonal anti-p44/42 ERK (1:1000; Cell Signaling). The im-
J.R., Greenberg, M.E., Sawyers, C.L., and Davis, R.J. (1997). A cyto-ages were scanned (AGFA DuoScan), and densitometry data were
plasmic inhibitor of the JNK signal transduction pathway. Scienceanalyzed using Quantity One Software (Bio-Rad).
277, 693–696.
Ferguson, I.A., and Johnson, E.J. (1991). Fibroblast growth factorElectroencephalography
receptor-bearing neurons in the CNS: identification by receptor-Surgical implantation of skull screw electrodes was performed with
mediated retrograde transport. J. Comp. Neurol. 313, 693–706.the mice positioned in a stereotaxic frame under halothane anesthe-
Fisher, R.S. (1989). Animal models of the epilepsies. Brain Res. Brainsia. Two active electrodes were placed over the right and left frontal
Res. Rev. 14, 245–278.cortex approximately 1 mm posterior to the bregma. A reference
electrode was implanted in the region over the frontal sinus. Refer- Frantz, K.J., and Van Hartesveldt, C. (1999). The locomotor effects of
ence EEG recordings from the right and left frontal regions were quinpirole in rats depend on age and gender. Pharmacol. Biochem.
performed using a Grass P5 Series AC amplifier with high and low Behav. 64, 821–826.
frequency filter settings at 100 and 1 Hz, respectively. The outputs Gernert, M., Hamann, M., Bennay, M., Loscher, W., and Richter, A.
of the amplifiers were digitized and stored using an analog-to-digital (2000). Deficit of striatal parvalbumin-reactive GABAergic interneu-
converter and Axoscope software. rons and decreased basal ganglia output in a genetic rodent model
of idiopathic paroxysmal dystonia. J. Neurosci. 20, 7052–7058.
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